Skip to content

CervoMed Inc.: 10-Q filed 2015-11-12

What CervoMed Inc. reported in its quarterly report filed 2015-11-12 (fiscal Q3 2015): 36 published measures, 94 facts as tagged in accession 0001437749-15-020645.

This filing

Form
10-Q (quarterly report)
Filed
2015-11-12
Fiscal period
fiscal Q3 2015
Accession
0001437749-15-020645 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CervoMed Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-09-3023,377,867USD
At 2014-12-3142,778,751USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-09-304,309,137USD
At 2014-12-314,613,126USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-09-3014,580,596USD
At 2014-12-3121,883,887USD
At 2014-09-3023,788,336USD
At 2013-12-31254,964USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-01-01 to 2015-09-30-7,025,064USD273
2014-01-01 to 2014-09-30-7,099,921USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-09-3028,227USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-3030,633,293USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-09-30-278,227USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-09-30-96,000,607USD
At 2014-12-31-75,290,374USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-07-01 to 2015-09-3018,614,968shares92
2015-01-01 to 2015-09-3018,614,968shares273
2014-07-01 to 2014-09-3018,671,121shares92
2014-01-01 to 2014-09-3012,155,041shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-07-01 to 2015-09-3018,614,968shares92
2015-01-01 to 2015-09-3018,614,968shares273
2014-07-01 to 2014-09-3018,671,121shares92
2014-01-01 to 2014-09-3012,155,041shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-01-01 to 2015-09-300USD273
2014-07-01 to 2014-09-30-145,999USD92
2014-01-01 to 2014-09-30-384,128USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-09-3063,389USD
At 2014-12-31102,315USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-09-301,613,854USD273
2014-01-01 to 2014-09-301,075,131USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-13,225,660USD92
2015-01-01 to 2015-09-30-20,715,551USD273
2014-07-01 to 2014-09-30-3,511,950USD92
2014-01-01 to 2014-09-30-6,684,949USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-09-3015,629,850USD
At 2014-12-3124,170,817USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-01 to 2014-09-3086,670USD92
2014-01-01 to 2014-09-30281,548USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-09-302,034,611USD
At 2014-12-312,338,600USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-09-30240,381USD
At 2014-12-31417,307USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2015-09-30985,000USD
At 2014-12-3112,055,991USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2015-09-306,449,628USD
At 2014-12-316,449,628USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2015-09-3013,225,660USD92
2015-01-01 to 2015-09-3020,715,551USD273
2014-07-01 to 2014-09-303,511,950USD92
2014-01-01 to 2014-09-306,684,949USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-07-01 to 2015-09-30692,709USD92
2015-01-01 to 2015-09-303,360,057USD273
2014-07-01 to 2014-09-301,273,186USD92
2014-01-01 to 2014-09-301,709,424USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-09-3018,614,968shares
At 2014-12-3118,614,968shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2015-09-3019,068,730USD
At 2014-12-3138,165,625USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-09-3079,139USD
At 2014-12-31109,034USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-09-3015,750USD
At 2014-12-316,719USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-13,224,495USD92
2015-01-01 to 2015-09-30-20,710,233USD273
2014-07-01 to 2014-09-30-3,595,469USD92
2014-01-01 to 2014-09-30-9,669,005USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-13,224,495USD92
2015-01-01 to 2015-09-30-20,710,233USD273
2014-07-01 to 2014-09-30-3,449,470USD92
2014-01-01 to 2014-09-30-9,284,877USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,456,567USD92
2015-01-01 to 2015-09-305,298,945USD273
2014-07-01 to 2014-09-301,869,840USD92
2014-01-01 to 2014-09-304,091,530USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-07-01 to 2015-09-305,393USD92
2015-01-01 to 2015-09-3017,875USD273
2014-07-01 to 2014-09-301,905USD92
2014-01-01 to 2014-09-308,971USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-07-01 to 2015-09-305,393USD92
2015-01-01 to 2015-09-3017,875USD273
2014-07-01 to 2014-09-30368,924USD92
2014-01-01 to 2014-09-30883,995USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-07-01 to 2014-09-30367,019USD92
2014-01-01 to 2014-09-30875,024USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,165USD92
2015-01-01 to 2015-09-305,318USD273
2014-07-01 to 2014-09-303,151USD92
2014-01-01 to 2014-09-303,597USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,165USD92
2015-01-01 to 2015-09-305,318USD273
2014-07-01 to 2014-09-30-83,519USD92
2014-01-01 to 2014-09-30-2,984,056USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-384,128USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-09-3031,773,293USD273

Inspect the source

Entity
CervoMed Inc. / CIK 0001053691
Captured
2026-09-20T05:17:36.273Z
SEC response SHA-256
0a28d9e08b18175e4a16bd2486e9ebae9dc8a6e8a3f7e429c0f71f98175b0255

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001053691.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))